Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
A recent report found that the number of opioid-related deaths in Ontario in the first 15 weeks of the COVID-19 pandemic was 38.2% higher than in the 15 weeks before the pandemic. Our study sought to determine if pharmacy professionals self-reported an increase or decrease in naloxone provision due...
Saved in:
Main Authors: | George Daskalakis (Author), Ashley Cid (Author), Kelly Grindrod (Author), Michael A. Beazely (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review
by: Ashley Cid, et al.
Published: (2021) -
Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial
by: Ashley Cid, et al.
Published: (2022) -
A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs
by: Hawraa Sameer Sajwani, et al.
Published: (2022) -
Who is using take-home naloxone? An examination of supersavers
by: Desiree Eide, et al.
Published: (2022) -
Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma
by: Ashley Cid, et al.
Published: (2024)